ATXS

Astria Therapeutics, Inc. ATXS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATXS JBIO ANEB MLYS ELVN ADAG LRMR BMEA ANNX
6M 105.69 % -90.25 % 137.90 % 214.63 % 26.11 % 27.45 % 140.88 % -4.00 % 108.05 %
YTD -7.36 % -90.34 % 46.84 % 244.16 % -12.89 % -5.34 % 8.73 % -54.47 % -43.64 %
1Y -24.93 % -87.88 % 26.78 % 210.23 % -24.97 % -11.76 % -39.86 % -83.86 % -58.16 %
3Y -13.26 % -98.46 % -15.64 % 128.63 % 101.74 % 50.00 % 40.65 % -82.05 % -46.18 %
5Y -78.29 % -98.86 % -67.32 % 128.63 % -73.77 % -93.50 % -71.74 % -90.12 % -89.46 %
10Y -98.36 % -98.86 % -67.32 % 128.63 % -65.30 % -93.50 % -98.36 % -90.12 % -82.55 %
From the beginning -98.93 % -98.86 % -67.32 % 128.63 % -65.30 % -93.50 % -98.16 % -90.12 % -82.55 %

Dividend

Jade Biosciences, Inc.